← Back to Search
Intensive Upper Limb Therapy for Stroke (SUPER Trial)
Houston, TX
N/A
Recruiting
Led By Sean Savitz
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Able to tolerate 6 hours of therapy a day
Single qualifying stroke event as confirmed by CT or MRI
Must not have
History of clinically significant ischemic or hemorrhagic stroke resulting in prior arm weakness in the same territory as the index stroke
Diagnosed with advanced dementia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (1 week prior to the intervention), within 1 week after the intervention, 6 weeks after intervention, 6 months after intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial explores the effects of intensive, high-quality upper limb therapy to improve motor skills, function, and quality of life.
See full description
Who is the study for?
The SUPER trial is for individuals who had a stroke at least 6 months ago, can follow instructions, and handle 6 hours of daily therapy. They should have moderate arm impairment (Fugl-Meyer score of 20-45) confirmed by imaging tests. People with prior significant arm injuries, severe pre-stroke disability, other strokes causing similar symptoms, medical instability, substance abuse issues or advanced dementia cannot participate.Check my eligibility
What is being tested?
This study tests an intensive upper extremity therapy program designed to improve the function and quality of life in chronic stroke survivors. It focuses on high-quality treatment that's both high-dose and high-intensity to see if it's feasible and effective.See study design
What are the potential side effects?
Since this trial involves physical therapy rather than medication, side effects may include muscle soreness or fatigue due to the intensity of the exercises. However, specific side effects will depend on individual tolerance to the therapy regimen.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can handle 6 hours of therapy daily.
show original
Select...
I had a stroke confirmed by a scan.
show original
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had a stroke before that caused weakness in my arm.
show original
Select...
I have been diagnosed with advanced dementia.
show original
Select...
I have had an arm injury that affects my ability to move it or causes significant pain.
show original
Select...
I was significantly independent before my stroke.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (1 week prior to the intervention), within 1 week after the intervention, 6 weeks after intervention, 6 months after intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (1 week prior to the intervention), within 1 week after the intervention, 6 weeks after intervention, 6 months after intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in functional arm movements as assessed by the Fugl Meyer-Upper Extremity Assessment
Change in functional gross and fine motor coordination as assessed by the Action Research Arm Test (ARAT)
Secondary study objectives
Change in anxiety as assessed by the Hospital Anxiety and Depression Scale (HADS)
Change in cognitive impairment as measured by the Montreal Cognitive Assessment (MoCA)
Change in degree of disability as assessed by the Modified Rankin Scale (mRS)
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Treatment
2013
Completed Phase 2
~10240
Find a Location
Closest Location:The University of Texas Health Science Center at Houston· Houston, TX· 998 miles
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
972 Previous Clinical Trials
361,027 Total Patients Enrolled
47 Trials studying Stroke
9,779 Patients Enrolled for Stroke
Sean SavitzPrincipal InvestigatorThe University of Texas Health Science Center, Houston
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your Fugl-Meyer upper extremity (UE) score is between 20 and 45.I can handle 6 hours of therapy daily.It has been over 6 months since my stroke.You are currently abusing drugs or alcohol.I had a stroke confirmed by a scan.I have had a stroke before that caused weakness in my arm.I have been diagnosed with advanced dementia.I have had an arm injury that affects my ability to move it or causes significant pain.I was significantly independent before my stroke.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.